- Health 2.0 Conference. 10 a 12 nov. 2014 - IV Simpósio de Modelagem do Controle da Dengue. 12 a 14 nov. 2014 - 7º Congresso da Sociedade Paulista de Parasitologia. 14 a 16 nov. 2014
EBOLA (1)
WARFIELD, K. L. et al. Vaccinating captive chimpanzees to save wild chimpanzees. PNAS, United States, v. 111, n. 24, p. 8873-8876, Jun. 2014.
(2) (3) (4) (5) (6) (7) (8) (9) (10)
GATHERER, D. The 2014 Ebola virus disease outbreak in West Africa. Journal of General Virology, London, v. 95, n. 8, p. 1619-1624, Aug. 2014.
LI, Y. H., CHEN, S. P. Evolutionary history of ebola virus. Epidemiology and Infection, Cambridge, v. 142, n. 1, p. 1138-1145, Jan. 2014.
UEBELHOER, L. S. et al. A High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and ebola viruses. Antiviral Research, [S.l.], v. 106, p. 86-94, Jun. 2014.
GARRISON, A. R. et al. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Research, [S.l.], v. 112, p. 1-7, Dez. 2014.
Case fatality rates of Ebola virus disease: a meta-analysis of World Health Organization data. Médecine el Maladies Infectieuses, Paris, v. 44, n. 9, p. 412-416, Sep. 2014.
WANG, Y., LIU, Z., DAI, Q. A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody. Virus Research, Madrid, v. 189, p. 254-261, Aug. 2014.
CHOWELL, G., NISHIURA, H. Transmission dynamics and control of ebola virus diasease (EVD): a review. BMC Medicine, London, v. 12, p. 196, Out. 2014.
HOENE, T.; FELDMANN, H. Ebolavirus in West Africa, and the use of experimental therapies or vaccines. BioMed Central, London, v. 12, p. 80, Sep. 2014.
O’BRIEN, L. et al. Vaccination with recombinant adenoviruses expressing ebola virus glycoprotein elicits protection in the interferon alphabeta receptor knock-out mouse. Virology, Washington, v. 452-453, p. 324-333, Mar. 2014.
DENGUE (2) (3) (4) (5)
(1)
MASSAD, E. et al. Risk of symptomatic dengue for foreign visitors to the 2014 FIFA World Cup in Brazil. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 109, n. 3, p. 394-397, Jun. 2014.
MACIEL-DE-FREITAS, R. et al. Discrepancies between Aedes aegypti identification in the field and in the laboratory after collection with a sticky trap Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 109, n. 6, p. 824-827, sept. 2014.
ISHIKAWA, T. ; YAMANAKA, A. ; KONISHI, E. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine, Kidlingtonv. 32, n.12, p. 1326-1337, Mar. 2014.
LOW, J. G. et al. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infectious Diseases, New York, v. 14, n. 8, p. 706-715, Aug. 2014.
MESSER, W. B. et al. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proceedings of the national academy of sciences of the United States of America, Washington, v. 111, n. 5, p. 1939-1944, Feb. 2014.
(1) (2) (3) (4) (5)
HINCAPIÉ ROJAS, V. P. ; CHAPARRO-GIRALDO, A. Estudio de libertad de operación para una línea genéticamente modificada de papa (Solanum tuberosum L.). Revista colombiana de biotecnologia, Bogotá, v. 16, n. 1, p. 119-128, ene.-jun. 2014.
HOFMAN, P. et al. Public-private relationships in biobanking: a still underestimated key component of open innovation. Virchows Arch, Berlin, v. 464, n. 1, p. 3-9, Jan. 2014.
SIEMIENIUCH, C. E; SINCLAIR, M. A. Extending systems ergonomics thinking to accommodate the socio-technical issues of Systems of Systems. Applied Ergonomics, Oxford, v. 45, n. 1, p. 85-98, Jan. 2014.
ATAL, V. ; BAR, T. Patent Quality and a Two-Tiered Patent System. Economic Journal, v. 62, n. 3, p. 503-540, Sep. 2014.
RACHINSKY, T. L. The future of prenatal molecular diagnostics: impact of the changing patent landscape. Pharmaceutical Patent Analyst, London, v. 3, n. 1, p. 1-3, 2014.
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br
